FOURNIER RESEARCH SEEKING PARTNER TO MARKET LIPIDIL (FENOFIBRATE)
Executive Summary
FOURNIER RESEARCH SEEKING PARTNER TO MARKET LIPIDIL (FENOFIBRATE) following the Dec. 31 approval of the triglyceride- lowering drug. The U.S. subsidiary of Dijon, France-based Fournier said its first priority will be to "finalize a partnership agreement" for the marketing of Lipidil. The company expects to launch the drug in the second half of 1994.